Stay updated on Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial page.

Latest updates to the Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedVersion update from v3.5.3 to v3.5.4, indicating a minor update to the page's documentation/system rather than a substantive change to study content.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe page revision metadata was updated from v3.5.2 to v3.5.3 on the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision updated: added v3.5.2 and removed v3.5.0.SummaryDifference0.0%

- Check75 days agoChange DetectedNapoli, Italy, 80131 has been changed to Naples, Italy, 80131. The revision label has been updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check90 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check111 days agoChange DetectedThe page revision updated from v3.4.1 to v3.4.2; this appears to be a minor version update with no user-facing content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial page.